A collaboration of researchers from two French University Hospitals, including one ENTIS member organisation, have published their CV-19 vaccine safety surveillance data. More information is available here.
» Read more
Researchers from the COVI-PREG research group have published data investigating the malformation risks following first trimester COVID-19 vaccination. More information is available here.
» Read more
Researchers from the HealthPartners Institute in Minneapolis, Minnesota (USA) have led the publication of a study using the Vaccine Safety Datalink (November 2021 to June 2022), comparing rates of third dose mRNA vaccine exposure in the 28 days prior to miscarriage or ongoing pregnancy. More information is available here.
» Read more
Researchers affiliated with the French and Swiss Covi-Preg registry, led by ENTIS members from the Swiss Teratology Information Service, have published a prospective cohort study describing the maternal and perinatal outcomes among unvaccinated pregnant women that tested positive for SARS-CoV-2 during the pre-Delta, Delta, and Omicron periods. More information can be found here.
» Read more
The latest evidence regarding the safety of COVID-19 vaccine in pregnancy has been published using data from the BORN Ontario population-based birth registry. The study provides evidence of decreased risks of preterm delivery and stillbirth following vaccination, with no significant increased risk of small for gestational age. More information can be found here.
» Read more
ENTIS affiliated researchers operating the Swiss COVI-PREG registry have published a multicentre prospective cohort study describing early adverse events and perinatal outcomes in pregnant women who received at least one dose of mRNA vaccine in Switzerland (n=1,012 pregnancies). More information can be found here.
» Read more
ENTIS research led by Dr Michael Ceulemans (Lareb TIS, Netherlands) and Prof Hedvig Nordeng (Pharmacoepidemiology and Drug Safety Research Group, University of Oslo) has been published describing the prevalence of medication use in pregnancy and breastfeeding during the first wave of the COVID-19 pandemic. The research highlighted that perinatal medication use was highly prevalent during the first wave, underlining the […]
» Read more
Ab updated overview of the impact of COVID-19 in pregnancy has recently been published in the American Journal of Obstetrics and Gynaecology. More information can be found here.
» Read more
Researchers from Mount Sinai Hospital, Toronto, Canada have published a narrative review of tocilizumab use for the treatment of COVID-19 in pregnancy. They located data describing 610 tocilizumab-exposed pregnancies, with 20 receiving treatment due to severe COVID-19. This review may be helpful for those providing counselling on the safety of COVID-19 treatments in pregnancy. More information can be found here. […]
» Read more
Researchers from the US CDC’s v-safe registry have published some preliminary data regarding the risk of miscarriage. Among women who were vaccinated either prior to pregnancy, or before 20 weeks gestational age, the age standardised cumulative risk of miscarriage was estimated to be 12.8% (95% CI: 10.8–14.8%), and in keeping with the expected background risk. More details can be found […]
» Read more